Abiopharma

Addus HomeCare Announces Second Quarter 2025 Financial Results

CVRx Reports Second Quarter 2025 Financial and Operating Results

Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences - Castle Biosciences Reports Second Quarter 2025 Results

New Form 4 - Altimmune, Inc. Filed: 2025-08-04 AccNo: 0001104659-25-073624 Size: 5 KB

New Form 8-K - TACTILE SYSTEMS TECHNOLOGY INC Filed: 2025-08-04 AccNo: 0001558370-25-010096 Size: 792 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 144 - INCYTE CORP Filed: 2025-08-04 AccNo: 0001950047-25-005377 Size: 7 KB

Best Brands For Laptops in 2025

Acadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data Officer

Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025

New Form SCHEDULE 13G/A - MYRIAD GENETICS INC Filed: 2025-08-04 AccNo: 0001104659-25-073620 Size: 18 KB

New Form D - InspireMD, Inc. Filed: 2025-08-04 AccNo: 0001641172-25-022037 Size: 16 KB

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference

Prothena - Prothena Reports Second Quarter 2025 Financial Results and Business Highlights